Laurel Wealth Advisors LLC Novartis Ag Transaction History
Laurel Wealth Advisors LLC
- $626 Million
- Q4 2024
A detailed history of Laurel Wealth Advisors LLC transactions in Novartis Ag stock. As of the latest transaction made, Laurel Wealth Advisors LLC holds 974 shares of NVS stock, worth $108,454. This represents 0.02% of its overall portfolio holdings.
Number of Shares
974
Previous 974
-0.0%
Holding current value
$108,454
Previous $112,000
16.07%
% of portfolio
0.02%
Previous 0.02%
Shares
10 transactions
Others Institutions Holding NVS
# of Institutions
1,479Shares Held
134MCall Options Held
1.31MPut Options Held
1.56M-
Dodge & Cox San Francisco, CA12.2MShares$1.36 Billion0.74% of portfolio
-
Primecap Management CO Pasadena, CA11MShares$1.23 Billion0.85% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.18MShares$911 Million0.2% of portfolio
-
Morgan Stanley New York, NY6.87MShares$765 Million0.05% of portfolio
-
Loomis Sayles & CO L P5.58MShares$621 Million0.68% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $240B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...